XBIT (XBiotech) Short Interest


XBIT XBiotech Inc XBIT
32 GF Score
Price $2.34
! 2 Warning Signs
View Full Analysis

What is XBiotech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XBIT vs FLNA, MCRB, TCRX: Short Interest Comparison

For the Biotechnology subindustry, XBiotech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XBiotech Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XBiotech's Short Interest distribution charts can be found below:

* The bar in red indicates where XBiotech's Short Interest falls into.


XBIT
32GF Score
XBiotech Inc XBIT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XBiotech Business Description

Other Exchanges 4XB:Germany
Address 5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
32GF Score

Get the complete analysis for XBIT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.34
Price